Uscom Limited (UCM.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -1.53 Million AUD | -94.45% |
| 2023 | -787.15 Thousand AUD | -108.84% |
| 2022 | -376.91 Thousand AUD | -42.01% |
| 2021 | -265.4 Thousand AUD | 7.91% |
| 2020 | -288.2 Thousand AUD | 76.15% |
| 2019 | -1.2 Million AUD | 51.54% |
| 2018 | -2.49 Million AUD | -49.89% |
| 2017 | -1.66 Million AUD | 41.42% |
| 2016 | -2.83 Million AUD | -439.56% |
| 2015 | -526.31 Thousand AUD | 66.75% |
| 2014 | -1.58 Million AUD | -192.47% |
| 2013 | -541.19 Thousand AUD | 0.6% |
| 2012 | -544.46 Thousand AUD | 74.38% |
| 2011 | -2.12 Million AUD | -54.44% |
| 2010 | -1.37 Million AUD | 27.91% |
| 2009 | -1.9 Million AUD | 23.78% |
| 2008 | -2.5 Million AUD | 42.39% |
| 2007 | -4.34 Million AUD | 39.76% |
| 2006 | -7.21 Million AUD | 31.45% |
| 2005 | -10.52 Million AUD | 0.0% |
| 2003 | -14.88 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -133.71 Thousand AUD | 0.0% |
| 2024 FY | -57.75 Thousand AUD | 92.66% |
| 2024 Q4 | -1.53 Million AUD | 0.0% |
| 2023 Q2 | -2.44 Million AUD | 0.0% |
| 2023 Q4 | -787.15 Thousand AUD | 0.0% |
| 2023 FY | -787.15 Thousand AUD | -108.84% |
| 2022 FY | -376.91 Thousand AUD | -42.01% |
| 2022 Q2 | -4.15 Million AUD | 0.0% |
| 2022 Q4 | -376.91 Thousand AUD | 0.0% |
| 2021 FY | -265.4 Thousand AUD | 7.91% |
| 2021 Q4 | -265.4 Thousand AUD | 0.0% |
| 2021 Q2 | -758.35 Thousand AUD | 0.0% |
| 2020 Q4 | -288.2 Thousand AUD | 0.0% |
| 2020 FY | -288.2 Thousand AUD | 76.15% |
| 2020 Q2 | 115.46 Thousand AUD | 0.0% |
| 2019 FY | -1.2 Million AUD | 51.54% |
| 2019 Q2 | -2.18 Million AUD | 0.0% |
| 2019 Q4 | -1.2 Million AUD | 0.0% |
| 2018 Q2 | -3.48 Million AUD | 0.0% |
| 2018 FY | -2.49 Million AUD | -49.89% |
| 2018 Q4 | -2.49 Million AUD | 0.0% |
| 2017 Q4 | -1.66 Million AUD | 0.0% |
| 2017 FY | -1.66 Million AUD | 41.42% |
| 2017 Q2 | -1.88 Million AUD | 0.0% |
| 2016 Q4 | -2.83 Million AUD | 0.0% |
| 2016 Q2 | -1.06 Million AUD | 0.0% |
| 2016 FY | -2.83 Million AUD | -439.56% |
| 2015 Q2 | -1 Million AUD | 0.0% |
| 2015 FY | -526.31 Thousand AUD | 66.75% |
| 2015 Q4 | -526.31 Thousand AUD | 0.0% |
| 2014 Q2 | -761.56 Thousand AUD | 0.0% |
| 2014 FY | -1.58 Million AUD | -192.47% |
| 2014 Q4 | -1.58 Million AUD | 0.0% |
| 2013 FY | -541.19 Thousand AUD | 0.6% |
| 2013 Q4 | -541.19 Thousand AUD | 0.0% |
| 2012 FY | -544.46 Thousand AUD | 74.38% |
| 2012 Q4 | -544.46 Thousand AUD | 0.0% |
| 2011 Q4 | -2.12 Million AUD | 0.0% |
| 2011 FY | -2.12 Million AUD | -54.44% |
| 2010 Q4 | -1.37 Million AUD | 0.0% |
| 2010 FY | -1.37 Million AUD | 27.91% |
| 2009 FY | -1.9 Million AUD | 23.78% |
| 2009 Q4 | -1.9 Million AUD | 0.0% |
| 2008 FY | -2.5 Million AUD | 42.39% |
| 2008 Q4 | -2.5 Million AUD | 0.0% |
| 2007 FY | -4.34 Million AUD | 39.76% |
| 2007 Q4 | -4.34 Million AUD | 0.0% |
| 2006 FY | -7.21 Million AUD | 31.45% |
| 2006 Q4 | -7.21 Million AUD | 0.0% |
| 2005 Q4 | -10.52 Million AUD | 0.0% |
| 2005 FY | -10.52 Million AUD | 0.0% |
| 2003 FY | -14.88 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 93.994% |
| Adherium Limited | -6.1 Million AUD | 74.925% |
| Aroa Biosurgery Limited | -3.74 Million AUD | 59.152% |
| Atomo Diagnostics Limited | -3.6 Million AUD | 57.522% |
| Anteris Technologies Ltd | -28.49 Million AUD | 94.629% |
| Control Bionics Limited | -19.02 Thousand AUD | -7946.646% |
| CardieX Limited | 2.74 Million AUD | 155.734% |
| Compumedics Limited | 5.08 Million AUD | 130.089% |
| Cochlear Limited | -269.9 Million AUD | 99.433% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 319.103% |
| Cyclopharm Limited | -7.49 Million AUD | 79.589% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | 90.252% |
| Nova Eye Medical Limited | -2.8 Million AUD | 45.374% |
| HeraMED Limited | -799.34 Thousand AUD | -91.485% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 110.569% |
| ImpediMed Limited | -23.48 Million AUD | 93.484% |
| InhaleRx Limited | -155.54 Thousand AUD | -884.051% |
| LBT Innovations Limited | -604 Thousand AUD | -153.416% |
| Micro-X Limited | 826.99 Thousand AUD | 285.083% |
| Neurotech International Limited | -2.11 Million AUD | 27.475% |
| OncoSil Medical Limited | -4.43 Million AUD | 65.454% |
| PolyNovo Limited | -30.52 Million AUD | 94.986% |
| Respiri Limited | 413.68 Thousand AUD | 469.996% |
| SomnoMed Limited | -15.16 Million AUD | 89.905% |
| Universal Biosensors, Inc. | -5.3 Million AUD | 71.142% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | 62.512% |